{2 (24 HR levomilnacipran 20 MG Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 MG Extended Release Oral Capsule) } Pack
- RxCUI
- 2636817
- RxNorm name
- {2 (24 HR levomilnacipran 20 MG Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 MG Extended Release Oral Capsule) } Pack
- Display name
- {2 (24 HR levomilnacipran 20 MG Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 MG Extended Release Oral Capsule) } Pack
- Full name
- {2 (24 HR levomilnacipran 20 MG Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 MG Extended Release Oral Capsule) } Pack
- Term type
- GPCK
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fetzima | LEVOMILNACIPRAN HYDROCHLORIDE | Allergan, Inc. | f371258d-91b3-4b6a-ac99-434a1964c3af | 2024-04-30 | Boxed warning, Warnings, Adverse reactions | 2636817 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f371258d-91b3-4b6a-ac99-434a1964c3af | {2 (24 HR levomilnacipran 20 MG Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 MG Extended Release Oral Capsule) } Pack [GPCK] · levomilnacipran 20 MG 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 MG 24HR Extended Release Oral Capsule (5) Pack [PSN] · levomilnacipran 20 MG 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 MG 24HR Extended Release Oral Capsule (5) Pack [SY] | 3 | 33 | These highlights do not include all the information needed to use FETZIMA safely and effectively. See full prescribing information for FETZIMA . FETZIMA ® ( levomilnacipran ) extended -release capsules, for oral use Initial U.S. Approval: 2009 (milnacipran) | 20240430 |